Publication:
Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.

dc.contributor.authorsKefeli, Umut; Arslan, Cagatay; Yildirim, Mahmut Emre; Isikdogan, Abdurrahman; Karadurmus, Nuri; Karabulut, Bulent; Cubukcu, Erdem; Cicin, Irfan; Yalcin, Suayib; Turk, Haci M.; Bilir, Cemil; Karaca, Mustafa; Artac, Mehmet; Sendur, Mehmet Nahit; Alacacioglu, Ahmet; Simsek, Eda Tanrikulu; Dane, Faysal; Bilici, Ahmet; Cevik, Duygu; Gumus, Mahmut
dc.date.accessioned2022-03-10T18:03:17Z
dc.date.accessioned2026-01-11T10:52:44Z
dc.date.available2022-03-10T18:03:17Z
dc.date.issued2021
dc.identifier.doi10.1200/JCO.2021.39.15_suppl.e15561
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/222463
dc.identifier.wosWOS:000708120301226
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleReal-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume39

Files